Cargando…
Development of a patient decision aid for superficial basal cell carcinoma
Autores principales: | van Delft, L.C.J., Essers, B.A.B., Nelemans, P.J., Mosterd, K., Kelleners‐Smeets, N.W.J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8246791/ https://www.ncbi.nlm.nih.gov/pubmed/33131075 http://dx.doi.org/10.1111/bjd.19662 |
Ejemplares similares
-
Quantitative survey into value clarification of discussed treatment options among patients treated for basal cell carcinoma
por: van Delft, L.C.J., et al.
Publicado: (2019) -
The additional diagnostic value of optical coherence tomography in clinically diagnosed basal cell carcinomas undergoing direct surgical excision
por: Adan, F., et al.
Publicado: (2021) -
Interventions for basal cell carcinoma: from evidence to personalized treatment
por: van Delft, L.C.J., et al.
Publicado: (2021) -
The illusion of conventional histological resection margin control
por: van Delft, L.C.J., et al.
Publicado: (2019) -
A trial‐based cost‐effectiveness analysis of topical 5‐fluorouracil vs. imiquimod vs. ingenol mebutate vs. methyl aminolaevulinate conventional photodynamic therapy for the treatment of actinic keratosis in the head and neck area performed in the Netherlands
por: Jansen, M.H.E., et al.
Publicado: (2020)